massively parallel sequencing
Singular Genomics Shares Soar on Deerfield Management Takeover Proposal
Funds and individuals associated with Deerfield control nearly 1 million shares of Singular, or approximately 27 percent of the firm, according to an SEC filing.
Pillar Biosciences, AstraZeneca Partner on Liquid Biopsy Testing in Europe
AstraZeneca has partnered with several other firms on liquid biopsies, including Angle, Sophia Genetics, IMBdx, and Guardant Health.
Next-Gen Sequencing Helps Tie Differences in Sequence Changes to Physics of DNA, Protein Binding
Premium
Two methods published simultaneously in Science use the Illumina MiSeq instrument to help increase the throughput of single-molecule biophysics studies.
For intrepid scientists, the hardware hack may unlock larger spatial biology studies that would be too expensive to run on commercial spatial omics platforms.
The firm has started working with a European consortium to put its instrumentation, which pairs ultrafast optics with efficient reagent usage, into practice.